Observational studyFrontiers in immunology2022

Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.

Gábor J Szebeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.